Assenagon Asset Management S.A. Cuts Stock Position in Corteva, Inc. $CTVA

Key Points

• Assenagon Asset Management cut its Corteva stake by 65% in the second quarter, selling 324,734 shares and retaining 174,783 shares valued at approximately $14.8 million. Institutional investors collectively own 81.54% of Corteva.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, but revenue of $6.38 billion fell short of expectations and declined 1.2% year over year. The company maintained fiscal 2026 EPS guidance of $3.60–$3.80.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $91.70, compared with the stock’s reported price of $76.28. Corteva also declared a quarterly dividend of $0.18 per share, equal to a 0.9% annualized yield.

Assenagon Asset Management S.A. lessened its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 65.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,783 shares of the company's stock after selling 324,734 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Corteva were worth $14,802,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva during the 4th quarter worth $27,000. Bank of Jackson Hole Trust acquired a new position in Corteva during the 4th quarter valued at about $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva in the fourth quarter valued at about $29,000. Finally, Basepoint Wealth LLC purchased a new stake in Corteva in the fourth quarter valued at about $30,000. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Stock Down 0.7%

CTVA opened at $76.28 on Tuesday. The company has a fifty day moving average of $81.90 and a two-hundred day moving average of $79.95. The stock has a market capitalization of $50.89 billion, a price-to-earnings ratio of 50.52, a PEG ratio of 2.36 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period in the prior year, the company posted $2.20 EPS. The company's revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is presently 47.68%.

Analysts Set New Price Targets

CTVA has been the topic of a number of research analyst reports. Rothschild & Co Redburn boosted their price target on Corteva from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 29th. BMO Capital Markets increased their price objective on shares of Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, August 3rd. Bank of America lifted their target price on shares of Corteva from $90.00 to $96.00 and gave the stock a "buy" rating in a research note on Monday, July 20th. Oppenheimer boosted their target price on shares of Corteva from $89.00 to $95.00 and gave the stock an "outperform" rating in a research report on Thursday, July 23rd. Finally, BNP Paribas Exane upped their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $91.70.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source